Fig. 2: The impact of cytogenetic risk on allogeneic stem cell transplantation outcomes in patients with secondary acute myeloid leukemia.

a OS-overall survival; b LFS- leukemia-free survival; c GRFS-graft -versus- host disease- free, relapse- free survival; d RI-relapse incidence; e NRM-non-relapse mortality.